[1]
|
Palli, D., Menegatti, M., Masala, G., et al. (2002) Helicobacter Pylori Infection, Anti-cagA Antibodies and Peptic Ulcer: A Case-Control Study in Italy. Alimentary Pharmacology & Therapeutics, 16, 1015-1020.
http://dx.doi.org/10.1046/j.1365-2036.2002.01253.x
|
[2]
|
Graham, D.Y. (2015) Helicobacter pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits. Gastroenterology, 148, 719-731.e3. http://dx.doi.org/10.1053/j.gastro.2015.01.040
|
[3]
|
Bayerdorffer, E. and Morgner, A. (2000) Gastric Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type: Management of the Disease. Digestive and Liver Disease, 32, 192-194.
http://dx.doi.org/10.1016/S1590-8658(00)80819-1
|
[4]
|
Graham, D.Y. and Fischbach, L. (2010) Helicobacter pylori Treatment in the Era of Increasing Antibiotic Resistance. Gut, 59, 1143-1153. http://dx.doi.org/10.1136/gut.2009.192757
|
[5]
|
Tong, J.L., Ran, Z.H., Shen, J., Zhang, C.X. and Xiao, S.D. (2007) Meta-Analysis: The Effect of Supplementation with Probiotics on Eradication Rates and Adverse Events during Helicobacter pylori Eradication Therapy. Alimentary Pharmacology & Therapeutics, 25, 155-168. http://dx.doi.org/10.1111/j.1365-2036.2006.03179.x
|
[6]
|
Malfertheiner, P., Megraud, F., O’Morain, C.A., et al. (2012) Management of Helicobacter pylori Infection—The Maastricht IV/ Florence Consensus Report. Gut, 61, 646-664. http://dx.doi.org/10.1136/gutjnl-2012-302084
|
[7]
|
Dang, Y., Reinhardt, J.D., Zhou, X. and Zhang, G. (2014) The Effect of Probiotics Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Eradication Therapy: A Meta-Analysis. PLoS One, 9, e111030.
http://dx.doi.org/10.1371/journal.pone.0111030
|
[8]
|
Lionetti, E., Indrio, F., Pavone, L., Borrelli, G., Cavallo, L. and Francavilla, R. (2010) Role of Probiotics in Pediatric Patients with Helicobacter pylori Infection: A Comprehensive Review of the Literature. Helicobacter, 15, 79-87.
http://dx.doi.org/10.1111/j.1523-5378.2009.00743.x
|
[9]
|
Liberati, A., Altman, D.G., Tetzlaff, J., et al. (2009) The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration. Annals of Internal Medicine, 151, W65-W94. http://dx.doi.org/10.7326/0003-4819-151-4-200908180-00136
|
[10]
|
Higgins, J.P.T. and Green, S. (2006) Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. In: The Cochrane Library, Issue 4, John Wiley & Sons Ltd., Chichester.
|
[11]
|
Higgins, J.P., Altman, D.G., Gotzsche, P.C., et al. (2011) The Cochrane Collaboration’s Tool for Assessing Risk of Bias in Randomised Trials. British Medical Journal, 343, Article ID: d5928. http://dx.doi.org/10.1136/bmj.d5928
|
[12]
|
Higgins, J.P., Thompson, S.G., Deeks, J.J. and Altman, D.G. (2003) Measuring Inconsistency in Meta-Analyses. British Medical Journal, 327, 557-560. http://dx.doi.org/10.1136/bmj.327.7414.557
|
[13]
|
Worona-Dibner, L.B. (2009) Randomized, Double-Blind, Placebo-Controlled Trial: Effect of Lactobacillus GG Supplementation on Helicobacter Pylori Eradication Rates and Side Effects during Treatment in Children. Revista de Gastroenterología de México, 74, 142-143.
|
[14]
|
Padilla Ruiz, M., Fernandez Aguiar, M.E., Arce Nunez, M. and Polo Amorin, R. (2013) Lactobacillus rhamnosus GG Supplementation to Reduce Side-Effects of Anti-Helicobacter Pylori Treatment. Revista de Gastroenterología del Perú, 33, 121-130.
|
[15]
|
Armuzzi, A., Cremonini, F., Ojetti, V., et al. (2001) Effect of Lactobacillus GG Supplementation on Antibiotic-Associated Gastrointestinal Side Effects during Helicobacter pylori Eradication Therapy: A Pilot Study. Digestion, 63, 1-7.
http://dx.doi.org/10.1159/000051865
|
[16]
|
Armuzzi, A., Cremonini, F., Bartolozzi, F., et al. (2001) The Effect of Oral Administration of Lactobacillus GG on Antibiotic-Associated Gastrointestinal Side-Effects during Helicobacter pylori Eradication Therapy. Alimentary Pharmacology & Therapeutics, 15, 163-169. http://dx.doi.org/10.1046/j.1365-2036.2001.00923.x
|
[17]
|
Cremonini, F., Di Caro, S., Covino, M., et al. (2002) Effect of Different Probiotic Preparations on Anti-Helicobacter Pylori Therapy-Related Side Effects: A Parallel Group, Triple Blind, Placebo-Controlled Study. American Journal of Gastroenterology, 97, 2744-2749. http://dx.doi.org/10.1111/j.1572-0241.2002.07063.x
|
[18]
|
Szajewska, H., Albrecht, P. and Topczewska-Cabanek, A. (2009) Randomized, Double-Blind, Placebo-Controlled Trial: Effect of Lactobacillus GG Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Treatment in Children. Journal of Pediatric Gastroenterology and Nutrition, 48, 431-436.
http://dx.doi.org/10.1097/MPG.0b013e318182e716
|
[19]
|
Higgins, J.P.T. and Green, S., Eds. (2005) Cochrane Handbook for Systematic Reviews of Interventions 4.2.4. John Wiley & Sons Ltd, Chichester.
|
[20]
|
Higgins, J.P.T. and Green, S., Eds. (2008) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration. http://www.cochrane-handbook.org
|
[21]
|
McFarland, L.V. (2006) Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease. American Journal of Gastroenterology, 101, 812-822.
http://dx.doi.org/10.1111/j.1572-0241.2006.00465.x
|
[22]
|
Szajewska, H., Ruszczynski, M. and Radzikowski, A. (2006) Probiotics in the Prevention of Antibiotic-Associated Diarrhea in Children: A Meta-Analysis of Randomized Controlled Trials. Journal of Pediatrics, 149, 367-372.
http://dx.doi.org/10.1016/j.jpeds.2006.04.053
|
[23]
|
Wang, Z.H., Gao, Q.Y. and Fang, J.Y. (2013) Meta-Analysis of the Efficacy and Safety of Lactobacillus-Containing and Bifidobacterium-Containing Probiotic Compound Preparation in Helicobacter pylori Eradication Therapy. Journal of Clinical Gastroenterology, 47, 25-32. http://dx.doi.org/10.1097/MCG.0b013e318266f6cf
|
[24]
|
Myllyluoma, E., Ahonen, A.M., Korpela, R., Vapaatalo, H. and Kankuri, E. (2008) Effects of Multispecies Probiotic Combination on Helicobacter pylori Infection in Vitro. Clinical and Vaccine Immunology, 15, 1472-1482.
http://dx.doi.org/10.1128/CVI.00080-08
|
[25]
|
Szajewska, H., Horvath, A. and Piwowarczyk, A. (2010) Meta-Analysis: The Effects of Saccharomyces boulardii Supplementation on Helicobacter pylori Eradication Rates and Side Effects during Treatment. Alimentary Pharmacology & Therapeutics, 32, 1069-1079. http://dx.doi.org/10.1111/j.1365-2036.2010.04457.x
|